Adverse selection in term life insurance purchasing due to the BRCA1/2 genetic test and elastic demand

Journal of Risk and Insurance

Volumn 74, Issue 1, 2007, Pages 65-86

  Viswanathan, Krupa S ^a   Lemaire, Jean ^b   Withers, Kate ^c   Armstrong, Katrina ^d   Baumritter, Agnieszka ^d   Hershey, John C ^b   Pauly, Mark V ^b   Asch, David A ^d,e  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GEORGETOWN UNIVERSITY LAW CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847695764     PISSN: 00224367     EISSN: 15396975     Source Type: Journal    
DOI: 10.1111/j.1539-6975.2007.00202.x     Document Type: Review

References (36)

1. American Academy of Actuaries, 1998, Genetic information and voluntary life insurance, Issue Brief.
2. American Academy of Actuaries, 2002, The use of genetic information in disability income and long-term care insurance, Issue Brief.
3. Antoniou, A., P. D. P. Pharoah, S. Narod, H. A. Risch, J. E. Eyjford, J. L. Hopper, N. Loman, H. Olsson, O. Johannsson, Å. Borg, B. Pasini, P. Radice, S. Manoukian, D. M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius, S. Thorlacios, H. Eerola, H. Nevanlinna, K. Syrj̈akoski, O.- P. Kallioniemi, D. Thompson, C. Evans, C. Peto, F. Lalloo, D. G. Evans, and D. F. Easton, 2003, Average Risks of Breast and Ovarian Cancer AssociatedWith BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, American Journal of Human Genetics, 72: 1117- 1130.
4. Bartram, C., J. Beckmann, F. Breyer, G. Fey, C. Fonatsch, B. Irrgang, J. Taupitz, K. Seel, and F. Thiele, 2000, Humangenetische Diagnostik, Wissenschaftliche Grundlagen und Gesellschaftliche Konsequenzen (Berlin: Springer-Verlag).
5. Begg, C. B., 2002, On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance, Journal of the National Cancer Institute, 94: 1221- 1226.
6. Berberich, K., and E. P. Fischer, 1999, Impact of Modern Genetics on Life Insurance, Cologne Re Publication 42.
7. Bernheim, B. D., 1991, How Strong are Bequest Motives? Evidence Based on Estimates of the Demand for Life Insurance and Annuities, Journal of Political Economy, 99: 899- 927.
8. Bernheim, B. D., K. Carman, J. Gokhale, and L. J. Kotlikoff, 2001, The Mismatch Between Life Insurance Holdings and Financial Vulnerabilities: Evidence From the Survey of Consumer Finances, NBER Working Paper No. 8455.
9. Breyer, F., 2001, Optionen für die Regulierung von Gentests im Versicherungswesen - Ökonomische Bewertung und Ausländische Erfahrungen. Cologne Re Seminar über Genetik in der Lebens- und Krankenversicherung.
10. Brose, M. S., T. R. Rebbeck, K. A. Calzone, J. E. Stopfer, K. L. Nathanson, and B. L. Weber, 2002, Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program, Journal of the National Cancer Institute, 94: 1365-1372.
11. Doble, A., 2001, Genetics in Society (Sidney: Institute of Actuaries of Australia).
12. Daykin, C. D., D. A. Akers, A. S. Macdonald, T. McGleenan, D. Paul, and P. J. Turvey, 2003, Genetics and Insurance-Some Social Policy Issues, British Actuarial Journal 9: 787-874.
13. Dicke, A., 2002, Perception vs. Reality. Life Insurance and Genetic Testing, Contingencies, November/December: 32-36.
14. Gandolfi, A., and L. Miners, 1996, Gender-Based Differences in Life Insurance Ownership, Journal of Risk and Insurance, 63: 683-693.
15. Houthakker, H., and L. Taylor, 1970, Consumer Demand in the United States (Cambridge: Harvard University Press).
16. Hoy, and Polborn, 2000, The Value of Genetic Information in the Life Insurance Market, Journal of Public Economics, 78: 235-252.
17. Jeffords, J. M., and T. Daschle, 2001, Political Issues in the Genome Era, Science, 291: 1249-1251.
18. Kite, M., 2001, Insurance Firm Admits Using Genetic Screening, The Times, February 8.
19. Knoppers, B. M., B. Godard, and Y. Joly, 2004,AComparative International Overview, in: M. Rothsten, ed., Genetics and Life Insurance-Medical Underwriting and Social Policy (Cambridge, MA: MIT Press).
20. Knowlan, W., 2004, Fact, Fiction in the Underwriting of Genetic Risks, Presented at the 35th ASTIN Colloquium, June 6-9, 2004. http://www.astin2004.no/ English/ pdf/William%20Nowlan.pdf.
21. Kotlikoff, L. J., and L. H. Summers, 1981, The Role of Intergenerational Transfers in Aggregate Capital Accumulation, Journal of Political Economy, 89: 706-732.
22. Lemaire, J., K. Subramanian, K. Armstrong, and D. A. Asch, 2000, Pricing Term Insurance in the Presence of a Family History of Breast and Ovarian Cancer, North American Actuarial Journal, 4: 75-87.
23. Lemmens, T., Y. Joly, and B. Knoppers, 2004, Genetics and Life Insurance: A Comparative Analysis, Genedit, II (2): 1-15. http://www.humgen. umontreal.ca/ en/GenEdit.cfm.
24. LIMRA International, 1996, 1993-94 United States Lapses by Duration and Product Line: Long-term Ordinary Lapse Survey, Transactions of the Society of Actuaries, 1995- 96 Reports, 411-435.
25. MacDonald, A., and D. Pritchard, 2000, A Mathematical Model of Alzheimer's Disease and the ApoE Gene, ASTIN Bulletin, 30: 69-110.
26. MacDonald, A., and D. Pritchard, 2001, Genetics, Alzheimer's disease and Long-Term Care Insurance, North American Actuarial Journal, 5: 54-78.
27. MacDonald, A., 2003, Moratoria on the Use of Genetic Tests and Family History for Mortage-Related Life Insurance, British Actuarial Journal, 9(I): 217-237.
28. MacDonald, A., H.Waters, and C.Wekwete, 2003, The Genetics of Breast and Ovarian Cancer. I. A Model of Family History. II. A Model of Critical Illness Insurance, Scandinavian Actuarial Journal, 1-27, 28-50.
29. MacMinn, R. D., P. L. Brockett, and J. A. Raeburn, 2004, Genetic Testing and Adverse Selection,Working Paper, Illinois State University.
30. Munich Reinsurance Company, 2004, Genetic Testing and Insurance-A Global View, 2nd Edition.
31. Myriad Genetic Laboratories, 2003, BRCA Analysis Technical Specifications.
32. National Center for Health Statistics, 2000, Vital statistics of the United States, 1997, Vol. I (Natality).
33. Pauly, M., K. Withers, K. S. Viswanathan, J. Lemaire, J. Hershey, K. Armstrong, and D. A. Asch, 2003, Price Elasticity of Demand for Term Life Insurance, NBER Working Paper 9925.
34. Subramanian, K., J. Lemaire, J. Hershey, M. Pauly, K. Armstrong, and D. A. Asch, 1999, Estimating Adverse Selection Costs from Genetic Testing for Breast and Ovarian Cancer: The Case of Life Insurance, Journal of Risk and Insurance, 66: 531-550.
35. Villeneuve, B., 2003, Mandatory Pensions and the Intensity of Adverse Selection in Life Insurance Markets, Journal of Risk and Insurance, 70: 527-548.
36. Watson Wyatt Insurance and Financial Services Review, May 2001.